Wagners Law Firm is continuing with its investigations concerning a class action lawsuit with respect to the link between ovarian cancer and the use of talcum powder manufactured by Johnson & Johnson, and marketed as Baby Powder.
Recent studies have indicated that ovarian cancer could occur from the use of talcum powder in the genital regions. Litigation is already occurring in the United States and Wagners are determining the viability of launching a Canadian class action concerning the use of Baby Powder, which contains talc, now noted to be possibly carcinogenic.
The studies, going as far back as the early 1980s, show an enhanced risk for the development of ovarian cancer from frequent use of talcum powder, such as the baby Powder brand made by Johnson & Johnson. In Canada, talcum powder has been noted to be high in toxicity and also a carcinogen.
This issue is continuing to cause great concern for Canadians who have used J&J Baby Powder for many years, both as a baby product and for female hygiene. Women who have ovarian cancer and used the talcum powder on a regular basis may have a potential claim in a class action lawsuit.
In August 2017, a jury in Los Angeles, California, awarded an amount of nearly $420 million to a receptionist who filed a lawsuit against Johnson & Johnson alleging that she developed ovarian cancer as a result of her use of J&J’s Baby Powder for many decades.